 |
| Neil Bhalodkar |
Neil Bhalodkar is joining Kestra Medical Technologies on March 3 as VP-investor relations. The Kirkland (WA)-based wearable medical devices company filed an initial public offering on Feb. 26.
With more than 20 years of experience, Bhalodkar headed IR at Inari Medical until it was acquired by Stryker. Similarly, he handled investor duties at Axionics, which was gobbled up by Boston Scientific.
Bhalodkar also worked IR at Sientra, and was an associate director at Steve Cohen’s Point72 asset management fund.
Kestra CEO Brian Webster said Bhalodkar’s "understanding of the MedTech ecosystem will be an asset to Kestra as we work to grow and evolve the wearable defibrillator market.”
More than 17K patients have worn Kestra’s Assure cardioverter defibrillators since their launch in August 2022. Kestra sees a potential $10B market for its cardio monitoring platform.
The Bain Capital portfolio company expects to raise more than $150M in the IPO, selling shares in the $14 to $16 range. Following completion of the IPO, Bain will own a 52.8 percent stake in Kestra
C Street Advisory handles iRobot Corp as the marketer of the Roomba autonomous vacuum cleaner files Chapter 11 after being squeezed by cheaper competitors.
Joele Frank represents Confluent Inc. as the Mountain View, CA-based data streaming platform company agrees to be acquired by IBM in a deal with an enterprise value of $11B.
Tom Johnson, who has headed H/Advisors Abernathy since 2016, will join FGS Global as global head of private capital & financial services, effective Dec. 16.
Brunswick Group and Gagnier Communications are handling Paramount’s $30 cash per-share offer for all of Warner Bros Discovery, topping Netflix $27.50 cash/stock transaction.
ICR Inc. handles communications for Enhanced Ltd, which plans to run Olympic-type competitions with athletes using performance-enhancing drugs, as it goes public in a SPAC deal valued at $1.2B via a merger with A Paradise Acquisition Corp. of Hong Kong.
